These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8479567)

  • 1. [Islet amyloid polypeptide or amylin; breakthrough in the diagnosis and prevention of type II diabetes mellitus?].
    Lips CJ; Höppener JW; Erkelens DW
    Ned Tijdschr Geneeskd; 1993 Apr; 137(15):754-7. PubMed ID: 8479567
    [No Abstract]   [Full Text] [Related]  

  • 2. Copper-mediated formation of hydrogen peroxide from the amylin peptide: a novel mechanism for degeneration of islet cells in type-2 diabetes mellitus?
    Masad A; Hayes L; Tabner BJ; Turnbull S; Cooper LJ; Fullwood NJ; German MJ; Kametani F; El-Agnaf OM; Allsop D
    FEBS Lett; 2007 Jul; 581(18):3489-93. PubMed ID: 17617411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "A" is for amylin and amyloid in type 2 diabetes mellitus.
    Hayden MR; Tyagi SC
    JOP; 2001 Jul; 2(4):124-39. PubMed ID: 11875249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A novel hormone in islet of pancreas--islet amyloid polypeptide].
    Wu SQ
    Sheng Li Ke Xue Jin Zhan; 1992 Jul; 23(3):260-3. PubMed ID: 1299966
    [No Abstract]   [Full Text] [Related]  

  • 5. [S20G mutation of amylin gene--amyloid diabetes due to S20G amylin gene mutation].
    Sanke T; Sakagashira S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():160-5. PubMed ID: 15779362
    [No Abstract]   [Full Text] [Related]  

  • 6. Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus.
    Hayden MR; Tyagi SC
    JOP; 2002 Jul; 3(4):86-108. PubMed ID: 12110767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide.
    Green JD; Kreplak L; Goldsbury C; Li Blatter X; Stolz M; Cooper GS; Seelig A; Kistler J; Aebi U
    J Mol Biol; 2004 Sep; 342(3):877-87. PubMed ID: 15342243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-scale imaging and dynamics of amylin-membrane interactions and its implication in type II diabetes mellitus.
    Cho WJ; Jena BP; Jeremic AM
    Methods Cell Biol; 2008; 90():267-86. PubMed ID: 19195555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid formation by pro-islet amyloid polypeptide processing intermediates: examination of the role of protein heparan sulfate interactions and implications for islet amyloid formation in type 2 diabetes.
    Meng F; Abedini A; Song B; Raleigh DP
    Biochemistry; 2007 Oct; 46(43):12091-9. PubMed ID: 17924651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal ultrastructure study of islet amyloid in the HIP rat model of type 2 diabetes mellitus.
    Hayden MR; Karuparthi PR; Manrique CM; Lastra G; Habibi J; Sowers JR
    Exp Biol Med (Maywood); 2007 Jun; 232(6):772-9. PubMed ID: 17526769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of amylin in the physiologic and physiopathologic regulation of energy metabolism].
    Cooper GJ
    Journ Annu Diabetol Hotel Dieu; 1991; ():125-39. PubMed ID: 1886326
    [No Abstract]   [Full Text] [Related]  

  • 12. The pathogenesis of maturity-onset diabetes mellitus: is there a link to islet amyloid polypeptide?
    Westermark P; Johnson KH
    Bioessays; 1988 Jul; 9(1):30-3. PubMed ID: 3063263
    [No Abstract]   [Full Text] [Related]  

  • 13. Copper(II) inhibits the formation of amylin amyloid in vitro.
    Ward B; Walker K; Exley C
    J Inorg Biochem; 2008 Feb; 102(2):371-5. PubMed ID: 18022240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and study of peptide-based inhibitors of amylin cytotoxicity.
    Muthusamy K; Arvidsson PI; Govender P; Kruger HG; Maguire GE; Govender T
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1360-2. PubMed ID: 20093026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet amyloid polypeptide: identification of long-range contacts and local order on the fibrillogenesis pathway.
    Padrick SB; Miranker AD
    J Mol Biol; 2001 May; 308(4):783-94. PubMed ID: 11350174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amylin: its potential role in the etiopathogenicity of diabetes mellitus].
    Artozqui Morrás E; Botella Serrano M; Camblor M; Bretón Lesmes I; Moreno Esteban B
    An Med Interna; 1993 Apr; 10(4):200-2. PubMed ID: 8513090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
    Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
    J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy.
    Soong R; Brender JR; Macdonald PM; Ramamoorthy A
    J Am Chem Soc; 2009 May; 131(20):7079-85. PubMed ID: 19405534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM).
    Westermark P
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S46-8. PubMed ID: 8894481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the heparin binding site in the N-terminus of human pro-islet amyloid polypeptide: implications for amyloid formation.
    Abedini A; Tracz SM; Cho JH; Raleigh DP
    Biochemistry; 2006 Aug; 45(30):9228-37. PubMed ID: 16866369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.